Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition.

Cheng F, Pekkonen P, Laurinavicius S, Sugiyama N, Henderson S, Günther T, Rantanen V, Kaivanto E, Aavikko M, Sarek G, Hautaniemi S, Biberfeld P, Aaltonen L, Grundhoff A, Boshoff C, Alitalo K, Lehti K, Ojala PM.

Cell Host Microbe. 2011 Dec 15;10(6):577-90. doi: 10.1016/j.chom.2011.10.011.

2.

Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV association.

Mwakigonja AR, Kaaya EE, Heiden T, Wannhoff G, Castro J, Pak F, Porwit A, Biberfeld P.

BMC Cancer. 2010 Jul 1;10:344. doi: 10.1186/1471-2407-10-344.

3.

Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.

Sarek G, Järviluoma A, Moore HM, Tojkander S, Vartia S, Biberfeld P, Laiho M, Ojala PM.

PLoS Pathog. 2010 Mar 19;6(3):e1000818. doi: 10.1371/journal.ppat.1000818.

4.

Autoimmunogenicity of the helix-loop-helix DNA-binding domain.

Petrakova N, Gudmundsdotter L, Yermalovich M, Belikov S, Eriksson L, Pyakurel P, Johansson O, Biberfeld P, Andersson S, Isaguliants M.

Mol Immunol. 2009 Apr;46(7):1467-80. doi: 10.1016/j.molimm.2008.12.013. Epub 2009 Jan 31.

PMID:
19181386
5.

Unsung hero Robert C. Gallo.

Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, Antonelli G, Bartholomew C, Bentwich Z, Bertazzoni U, Berzofsky JA, Biberfeld P, Boeri E, Buonaguro L, Buonaguro FM, Bukrinsky M, Burny A, Caruso A, Cassol S, Chandra P, Ceccherini-Nelli L, Chieco-Bianchi L, Clerici M, Colombini-Hatch S, de Giuli Morghen C, de Maria A, de Rossi A, Dierich M, Della-Favera R, Dolei A, Douek D, Erfle V, Felber B, Fiorentini S, Franchini G, Gershoni JM, Gotch F, Green P, Greene WC, Hall W, Haseltine W, Jacobson S, Kallings LO, Kalyanaraman VS, Katinger H, Khalili K, Klein G, Klein E, Klotman M, Klotman P, Kotler M, Kurth R, Lafeuillade A, La Placa M, Lewis J, Lillo F, Lisziewicz J, Lomonico A, Lopalco L, Lori F, Lusso P, Macchi B, Malim M, Margolis L, Markham PD, McClure M, Miller N, Mingari MC, Moretta L, Noonan D, O'Brien S, Okamoto T, Pal R, Palese P, Panet A, Pantaleo G, Pavlakis G, Pistello M, Plotkin S, Poli G, Pomerantz R, Radaelli A, Robertguroff M, Roederer M, Sarngadharan MG, Schols D, Secchiero P, Shearer G, Siccardi A, Stevenson M, Svoboda J, Tartaglia J, Torelli G, Tornesello ML, Tschachler E, Vaccarezza M, Vallbracht A, van Lunzen J, Varnier O, Vicenzi E, von Melchner H, Witz I, Zagury D, Zagury JF, Zauli G, Zipeto D.

Science. 2009 Jan 9;323(5911):206-7. doi: 10.1126/science.323.5911.206. No abstract available.

PMID:
19131607
6.

Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions.

Mwakigonja AR, Pyakurel P, Kokhaei P, Pak F, Lema LK, Kaaya EE, Biberfeld P.

Infect Agent Cancer. 2008 Jun 30;3:10. doi: 10.1186/1750-9378-3-10.

7.

Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis.

Koopal S, Furuhjelm JH, Järviluoma A, Jäämaa S, Pyakurel P, Pussinen C, Wirzenius M, Biberfeld P, Alitalo K, Laiho M, Ojala PM.

PLoS Pathog. 2007 Sep 7;3(9):1348-60.

8.

Kaposi's sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's sarcoma lesions.

Pak F, Mwakigonja AR, Kokhaei P, Hosseinzadeh N, Pyakurel P, Kaaya E, Bogdanovic G, Selivanova G, Biberfeld P.

Eur J Cancer. 2007 Aug;43(12):1877-82. Epub 2007 Jul 12.

PMID:
17627810
9.

Oral Kaposi's sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association.

Mwakigonja AR, Pak F, Pyakurel P, Mosha IJ, Urassa WK, Kaaya EE, Biberfeld P.

Oncol Rep. 2007 Jun;17(6):1291-9.

PMID:
17487381
10.

KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development.

Pyakurel P, Pak F, Mwakigonja AR, Kaaya E, Biberfeld P.

Infect Agent Cancer. 2007 Feb 2;2:4.

11.

A plea for justice for jailed medical workers.

Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, Hunter E, Klein G, Korber B, Kuritzkes DR, Lederman MM, Malim MH, Marx PA, McCune JM, McMichael A, Miller C, Miller V, Montagnier L, Montefiori DC, Moore JP, Nixon DF, Overbaugh J, Pauza CD, Richman DD, Saag MS, Sattentau Q, Schooley RT, Shattock R, Shaw GM, Stevenson M, Trkola A, Wainberg MA, Weiss RA, Wolinsky S, Zack JA.

Science. 2006 Nov 10;314(5801):924-5. Epub 2006 Oct 24. No abstract available.

PMID:
17062652
12.

Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma.

Biberfeld P, Ensoli B, Stürzl M, Schulz TF.

Curr Opin Infect Dis. 1998 Apr;11(2):97-105.

PMID:
17033372
13.

Hepatitis C virus core protein transforms murine fibroblasts by promoting genomic instability.

Smirnova IS, Aksenov ND, Kashuba EV, Payakurel P, Grabovetsky VV, Zaberezhny AD, Vonsky MS, Buchinska L, Biberfeld P, Hinkula J, Isaguliants MG.

Cell Oncol. 2006;28(4):177-90.

14.

CGH of microdissected Kaposi's sarcoma lesions reveals recurrent loss of chromosome Y in early and additional chromosomal changes in late tumour stages.

Pyakurel P, Montag U, Castaños-Vélez E, Kaaya E, Christensson B, Tönnies H, Biberfeld P, Heiden T.

AIDS. 2006 Sep 11;20(14):1805-12.

PMID:
16954721
15.

AIDS and non AIDS-related malignant lymphoma in Tanzania.

Kaaya EE, Castaños-Velez E, Ekman M, Mwakigonja A, Carneiro P, Lema L, Kitinya J, Linde A, Biberfeld P.

Afr Health Sci. 2006 Jun;6(2):69-75.

16.

Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I.

Catrina SB, Botusan IR, Rantanen A, Catrina AI, Pyakurel P, Savu O, Axelson M, Biberfeld P, Poellinger L, Brismar K.

Clin Cancer Res. 2006 Aug 1;12(15):4506-14.

17.

Peter Perlmann 1919-2005.

Hammarström S, Berzins K, Biberfeld P, Engvall E, Hammarström ML, Holm G, Troye-Blomberg M, Wahlgren M.

Scand J Immunol. 2006 Jun;63(6):487-9. No abstract available.

18.

Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development.

Pyakurel P, Pak F, Mwakigonja AR, Kaaya E, Heiden T, Biberfeld P.

Int J Cancer. 2006 Sep 15;119(6):1262-7.

19.

Coreceptor usage of primary HIV type 1 isolates obtained from different lymph node subsets.

Casper C, Mild M, Jansson M, Karlsson A, Holmberg V, Bratt G, Van Paaschen H, Biberfeld P, Björndal A, Albert J, Popovic M, Fenyö EM.

AIDS Res Hum Retroviruses. 2005 Dec;21(12):1003-10.

PMID:
16379603
20.

Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival.

Catrina SB, Lewitt M, Massambu C, Dricu A, Grünler J, Axelson M, Biberfeld P, Brismar K.

Br J Cancer. 2005 Apr 25;92(8):1467-74.

21.

HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry.

Pak F, Pyakural P, Kokhaei P, Kaaya E, Pourfathollah AA, Selivanova G, Biberfeld P.

J Cutan Pathol. 2005 Jan;32(1):21-7.

PMID:
15660651
22.

Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.

Shao JY, Ernberg I, Biberfeld P, Heiden T, Zeng YX, Hu LF.

Anticancer Res. 2004 Jul-Aug;24(4):2309-18.

23.

A synthetic peptide derived from the human eosinophil-derived neurotoxin induces apoptosis in Kaposi's sarcoma cells.

Dricu A, Sergiu-Bogdan C, Brismar K, Biberfeld P, Andersson LC.

Anticancer Res. 2004 May-Jun;24(3a):1427-32.

24.

Human herpesvirus 8/Kaposi sarcoma herpesvirus cell association during evolution of Kaposi sarcoma.

Pyakurel P, Massambu C, Castaños-Vélez E, Ericsson S, Kaaya E, Biberfeld P, Heiden T.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):678-83.

PMID:
15167286
25.

Dichotomy between CD1a+ and CD83+ dendritic cells in lymph nodes during SIV infection of macaques.

Söderlund J, Nilsson C, Loré K, Castanos-Velez E, Ekman M, Heiden T, Biberfeld G, Andersson J, Biberfeld P.

J Med Primatol. 2004 Feb;33(1):16-24.

PMID:
15061728
26.

Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.

Massambu C, Pyakurel P, Kaaya E, Enbom M, Urassa W, Demirhan I, Loewer J, Linde A, Chandra A, Heiden T, Doerr HW, Chandra P, Biberfeld P.

Anticancer Res. 2003 May-Jun;23(3B):2389-95.

PMID:
12894519
27.

Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.

Baecklund E, Sundström C, Ekbom A, Catrina AI, Biberfeld P, Feltelius N, Klareskog L.

Arthritis Rheum. 2003 Jun;48(6):1543-50.

28.

Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients.

Chandra A, Demirhan I, Massambu C, Pyakurel P, Kaaya E, Enbom M, Urassa W, Linde A, Heiden T, Biberfeld P, Doerr HW, Cinatl J, Loewer J, Chandra P.

Anticancer Res. 2003 Jan-Feb;23(1B):723-8. Erratum in: Anticancer Res. 2003;23:5370.

PMID:
12680174
29.

Simian AIDS-related lymphoma growth in severe combined immunodeficiency mice is independent of karyotypic abnormalities or Bcl-6 mutations.

Castaños-Vélez E, Heiden T, Lindvall C, Capello D, Sandlund A, Imreh S, Blennow E, Andersson LC, Gaidano G, Nordenskjöld M, Biberfeld P.

AIDS Res Hum Retroviruses. 2002 Mar 20;18(5):383-90.

PMID:
11897040
30.

Mother-to-Child transmission of HIV-1. Meeting of world Federation of Scientists in Erice, Italy, august 2001. Joint working group report of AIDS and infectious diseases PMP, and mother and child health PMP Plea for action with special emphasis on antiretroviral therapy: a scientific and community challenge.

Biberfeld G, Biberfeld P, Buonaguro F, Charpak N, de Thé erreira Rea M, Gray G, Huraux C, Lindberg A, Samuel NM, Scarlatti G, Tlou S, Van de Perre P, Yi Z, Zetterström R.

Acta Paediatr. 2001 Nov;90(11):1337-9. No abstract available.

PMID:
11808909
31.

Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern.

Rezvany MR, Jeddi-Tehrani M, Biberfeld P, Söderlund J, Mellstedt H, Osterborg A, Rabbani H.

Br J Haematol. 2001 Nov;115(2):263-71.

PMID:
11703320
32.

Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.

Linder S, Castaños-Velez E, von Rosen A, Biberfeld P.

Hepatogastroenterology. 2001 Sep-Oct;48(41):1321-7.

PMID:
11677955
33.

Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.

Colmenero P, Berglund P, Kambayashi T, Biberfeld P, Liljeström P, Jondal M.

Gene Ther. 2001 Sep;8(17):1307-14.

34.

Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys.

Walther-Jallow L, Nilsson C, Söderlund J, ten Haaft P, Mäkitalo B, Biberfeld P, Böttiger P, Heeney J, Biberfeld G, Thorstensson R.

J Gen Virol. 2001 Jul;82(Pt 7):1601-12.

PMID:
11413371
35.

Kaposi's sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children.

Amir H, Kaaya EE, Manji KP, Kwesigabo G, Biberfeld P.

Pediatr Infect Dis J. 2001 May;20(5):518-21.

PMID:
11368110
36.

Proliferation and apoptosis in the evolution of endemic and acquired immunodeficiency syndrome-related Kaposi's sarcoma.

Kaaya E, Castaños-Vélez E, Heiden T, Ekman M, Catrina AI, Kitinya J, Andersson L, Biberfeld P.

Med Oncol. 2000 Nov;17(4):325-32.

PMID:
11114713
37.

Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.

Enbom M, Sheldon J, Lennette E, Schulz T, Ablashi DV, Neipel F, Biberfeld P, Carlberg H, Ljungman P, Nilsson A, Söderström T, Wadström J, Linde A.

J Med Virol. 2000 Dec;62(4):498-504.

PMID:
11074479
38.

The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2.

Ojala PM, Yamamoto K, Castaños-Vélez E, Biberfeld P, Korsmeyer SJ, Mäkelä TP.

Nat Cell Biol. 2000 Nov;2(11):819-25.

39.

Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey.

Ohara N, Hayashi K, Teramoto N, Oka T, Fujimoto K, Yoshikawa Y, Castanos-Velez E, Biberfeld P, Akagi T.

Intervirology. 2000;43(2):102-6.

PMID:
10971128
40.

Combined analysis of DNA ploidy, proliferation, and apoptosis in paraffin-embedded cell material by flow cytometry.

Heiden T, Castaños-Vélez E, Andersson LC, Biberfeld P.

Lab Invest. 2000 Aug;80(8):1207-13.

PMID:
10950111
41.

Antibody spectrum against the viral transactivator protein in patients with human immunodeficiency virus type 1 infection and Kaposi's sarcoma.

Demirhan I, Chandra A, Mueller F, Mueller H, Biberfeld P, Hasselmayer O, Chandra P.

J Hum Virol. 2000 May-Jun;3(3):137-43.

PMID:
10881993
42.

Anti-CD3 induced thymocyte apoptosis in vivo require the antibody Fc domain.

Xue Y, Castanos-Velez E, Biberfeld P, Jondal M.

Scand J Immunol. 2000 May;51(5):441-6.

43.

Recruitment of monocyte derived dendritic cells ex vivo from SIV infected and non-infected cynomolgus monkeys.

Söderlund J, Nilsson C, Ekman M, Walther L, Gaines H, Biberfeld G, Biberfeld P.

Scand J Immunol. 2000 Feb;51(2):186-94.

44.

Detection of distinct patterns of anti-tat antibodies in HIV-infected individuals with or without Kaposi's sarcoma.

Demirhan I, Chandra A, Hasselmayer O, Biberfeld P, Chandra P.

J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):364-8.

PMID:
10634198
45.

Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function.

Axdorph U, Porwit-MacDonald A, Sjöberg J, Grimfors G, Ekman M, Wang W, Biberfeld P, Björkholm M.

Br J Cancer. 1999 Dec;81(7):1182-7.

46.

Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells.

Stürzl M, Hohenadl C, Zietz C, Castanos-Velez E, Wunderlich A, Ascherl G, Biberfeld P, Monini P, Browning PJ, Ensoli B.

J Natl Cancer Inst. 1999 Oct 20;91(20):1725-33.

PMID:
10528022
47.

Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6.

Ojala PM, Tiainen M, Salven P, Veikkola T, Castaños-Vélez E, Sarid R, Biberfeld P, Mäkelä TP.

Cancer Res. 1999 Oct 1;59(19):4984-9.

48.

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.

Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A.

J Exp Med. 1999 Oct 4;190(7):1025-32.

49.

A cytotoxic, apoptotic, low-molecular weight factor from pineal gland.

Catrina SB, Catrina AI, Sirzén F, Griffiths W, Bergman T, Biberfeld P, Coculescu M, Mutt V.

Life Sci. 1999;65(10):1047-57.

PMID:
10499872
50.

Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.

Gaidano G, Castaños-Velez E, Biberfeld P.

Med Oncol. 1999 Apr;16(1):8-12.

PMID:
10382936

Supplemental Content

Loading ...
Support Center